Weston, Florida – 12/06/2018 – Pyramidion Technology Group, Inc. (OTCPK:PYTG), LeafyWell (www.LeafyWell.com) produces a broad selection of Cannabidiol (“CBD”) containing products such as tinctures, oils, creams and lotions, and edible gummy candies has announced today that they will expand its product lines to include specifically formulated sprays and treats designed for pets to address anxiety, nervousness, arthritis and inflammation, and ailments in digestion, among others.

Research investigating the effects of CBD have produced positive findings thereby supporting its use in the treatment of a variety of conditions and ailments such as rheumatoid arthritis, diabetes, post-traumatic stress disorder, epilepsy, antibiotic-resistant infections, neurological disorders, and muscular dystrophy in humans. LeafyWell www.LeafyWell.com is now branching out with pet specific formulations designed for a variety of health concerns in animals with delivery methods intended to be suitable for domesticated pets including both treats and sprays. Currently, dog and cat treats are offered in the following flavors: Bacon, Steak, Jerky, Pigs in a Blanket, Bones and Meatballs. The current collection line of pet designed sprays have no added flavor and are designed to be added to either food or water, or given orally directly to pets.

According to some reported statistics, the pet treat industry is a billion-dollar industry placing pet treat sales upwards of $5 billion dollars in the US alone in 2018 while pet food sales exceed $25 billion dollars. Moreover, it has also been reported that around 24% of owners seek out treats designed to address specific health issues. The LeafyWell www.LeafyWell.com pet collection is currently available via e-commerce and perhaps in the future we will see the entire product line on display shelves in retail brick and mortar pet stores and directly purchasable online via pet store websites.

Our collection of CBD LeafyWell Pet products can be found at the following web addresses:

“We are excited to announce our newest product line offerings to include formulations and delivery methods designed specifically for dogs and cats. Our intention is to offer a staple in home pet products for consumers available for purchase in a variety of methods and in a variety of flavors and delivery methods. The pet industry appears to be ready for our products and we anticipate great things to come for our clients and our investors from our pet product line launch. We also feel that the timing of our launch is right on schedule with our company’s goals as well as making our products available just in time for the holidays.”, states Carlos Hurtado, CEO of PYTG.

Pyramidion Technology Group, Inc. (“PYTG” or the “Company”) is best described as a business incubator. The purpose of our business model is to leverage equity, to acquire, merge and or joint venture with early stage companies in emerging sectors, to facilitate growth and cash flow utilizing a diverse distribution method.

Our intention is to develop and acquire fast growing companies in up-trending industries and positioning technology for economic growth. This platform will combine natural relationships, marketing synergies and distribution methods that enable combined companies to provide a wide variety of unique and complete solutions, services and necessities to consumers. We believe our overall business model could effectively create a company of unlimited opportunities for our growing shareholder base.

To be added to the Company investor email list, please email info@pytgcorp.com with PYTG in the subject line.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

For a discussion of these risks and uncertainties, please see our filings with the OTC Markets Group Inc. Our public filings with the OTC Markets Group Inc are available from commercial document retrieval services and at the website maintained by the OTC Markets at https://www.otcmarkets.com/stock/PYTG/filings.

FOLLOW US

FinancialNewsMedia.com (FNM) is a third party publisher and news dissemination solutions provider of multimedia platforms that enable officers & directors, corporate communicators, public relations and investor relations officers to leverage content to engage with all their key audiences. Any ideas and opinions presented in any FNM News Alerts, Video clips, Press Releases, RSS Feeds or Social Network Posts are for informational purposes only, and do not reflect the opinions of FNM or any of its affiliates, subsidiaries or partners. UNDER NO CIRCUMSTANCES SHOULD ANY CONTENT CONTAINED HEREIN BE INTERPRETED TO REPRESENT TRADING OR INVESTMENT ADVICE. All viewers agree that under no circumstances will FNM, its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information contained on this or any affiliated website.